A new urology lab with advanced diagnostic testing is up and running at UPMC St. Margaret Hospital to deal with a slow but ...

EMA committee recommends marketing approval for Bayer’s Nubeqa for patients with advanced prostate cancer: Berlin Saturday, June 21, 2025, 10:00 Hrs [IST] The Committee for Medi ...

Archeus hopes to begin a Phase I trial of the PSMA-targeted agent in metastatic, castration-resistant prostate cancer later this year.

Recently, I was diagnosed with BPH. This is all new to me, and I hope you can help me better understand the condition and how ...

The Prostate Cancer Market is set to grow from USD 11.7 Billion in 2022 to USD 21.6 Billion by 2031, driven by rising cases in targeted therapies. The U.S. Prostate Cancer Market is expanding rapidly ...

Prostate cancer is treatable but there’s no way to know if it will return That’s why it’s important to take proactive steps ...

Two cancer survivors are urging others to get checked as their colleagues prepare to take on the Three Peaks in aid of three ...

A tool developed by a scientist at UVA’s School of Nursing can help prostate cancer patients make important decisions when it comes to treatment options.

"Cancer changes you and everyone around you. That’s not a cliché. For me, it brought anxiety, urgency and openness." ...

The Philadelphia Conquering Cancer Coalition aims to remove barriers and improve communication and collaboration between ...

The Maine Senate's refusal to waive the waiting period between requesting and receiving life-ending prescriptions is ...

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...